Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Schedules,Therapeutic_group
Roche,Vismodegib,"Basal cell carcinoma, locally advanced or metatastic",Vismodegib,,Oncology Agents and Immunosuppressants
